"UnitedHealth reported adjusted EPS of $7.23 against an estimate of $6.61, a beat of 9%. Revenue came in at $111.72 billion versus estimates of $109.66 billion, growing 2% year over year."
"The medical cost ratio improved 90 basis points to 83.9%, signaling that cost trends are moving in the right direction after a brutal stretch."
"Management also committed to at least $2.0 billion in share buybacks by the end of Q2 2026, indicating a strong cash flow position."
"UnitedHealth raised its full-year 2026 adjusted EPS outlook to greater than $18.25 per share, giving investors a concrete forward signal that management sees the cost improvement holding."
UnitedHealth Group's stock increased by 9% following a Q1 2026 earnings report that exceeded expectations and raised its full-year outlook. The company's adjusted EPS was $7.23, surpassing estimates of $6.61, while revenue reached $111.72 billion, above the $109.66 billion forecast. The medical cost ratio improved to 83.9%, indicating positive cost trends. UnitedHealth also announced a commitment to $2.0 billion in share buybacks and raised its adjusted EPS outlook for 2026 to over $18.25 per share, signaling confidence in ongoing cost improvements.
Read at 24/7 Wall St.
Unable to calculate read time
Collection
[
|
...
]